• About Us
    • Company Overview
    • Leadership
    • Board of Directors
    • Business Advisors
    • Scientific Advisory Board
    • Corporate Governance
  • Our Focus
    • COVID-19 and CVD
    • Acute Myocarditis
    • Heart Failure
    • R&D Partners
    • Our Science
    • Resources
  • Products
  • Investors
    • Events & Presentations
    • Press Releases
    • Analyst Coverage
    • Stock Information
    • Filings & Financials
    • AGM
    • Contact Us
  • Press Releases
  • Stock Information
  • Filings & Financials
  • AGM
  • Events & Presentations
  • Analyst Coverage
  • Investor Relations Contacts
Investors

Financials

  2020 2019
Consolidated Financial Statements Q1Q2Q3Q4 Q1Q2Q3Q4
MD&A Q1Q2Q3Q4 Q1Q2Q3Q4

Regulatory Filings

For a full list of Cardiol Therapeutics’ regulatory filings, please visit SEDAR (Canadian Public Filings).

Financial Downloads

Cardiol Therapeutics – 2019 Year End Financial Statements
Cardiol Therapeutics – 2019 Year End MD&A
Cardiol Therapeutics – 2018 Year End Financial Statements
Cardiol Therapeutics – 2018 Year End MD&A

 

  • About Us
  • Our Focus
  • Investors
  • Contact

TSX: CRDL OTCQX: CRTPF

 

Sign up to receive the latest news from Cardiol Therapeutics

© 2021 Cardiol Therapeutics Inc. All rights reserved.      Terms of Use      Privacy Policy